Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.

[1]  E. Simpson,et al.  Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  D. Boudreau,et al.  Associations between diabetes medication use and risk of second breast cancer events and mortality , 2015, Cancer Causes & Control.

[3]  G. D'aiuto,et al.  Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype , 2014, Diabetology & Metabolic Syndrome.

[4]  A. Yang,et al.  Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R , 2014, BMC Cancer.

[5]  Francisco Gude,et al.  Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study , 2013, BMC Endocrine Disorders.

[6]  C. Perou,et al.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  P. Boyle,et al.  Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis , 2013, European Journal of Nutrition.

[8]  G. D'aiuto,et al.  Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience , 2013, Journal of experimental & clinical cancer research : CR.

[9]  M. Rinaldo,et al.  Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series , 2013, BMC Cancer.

[10]  S. Gapstur,et al.  Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults , 2012, Diabetes Care.

[11]  R. Nahta.  Deciphering the Role of Insulin-Like Growth Factor-I Receptor in Trastuzumab Resistance , 2012, Chemotherapy research and practice.

[12]  E. Negri,et al.  Diabetes Mellitus and Cancer Risk in a Network of Case-Control Studies , 2012, Nutrition and cancer.

[13]  G. Botti,et al.  Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  B. Pockaj,et al.  The Impact of Obesity on Breast Cancer: A Retrospective Review , 2012, Annals of Surgical Oncology.

[15]  E. Lerma,et al.  Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas , 2012, British Journal of Cancer.

[16]  B. Spiegelman,et al.  Molecular mechanisms of cancer development in obesity , 2011, Nature Reviews Cancer.

[17]  K. Basen-Engquist,et al.  Obesity and Cancer Risk: Recent Review and Evidence , 2011, Current oncology reports.

[18]  Jason I. Herschkowitz,et al.  Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.

[19]  Laura Sciacca,et al.  Diabetes and cancer. , 2009, Endocrine-related cancer.

[20]  M. Pollak,et al.  Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.

[21]  P. Porter,et al.  Body Size and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer in Postmenopausal Women , 2008, Cancer Epidemiology Biomarkers & Prevention.

[22]  C. Perou,et al.  Epidemiology of basal-like breast cancer , 2008, Breast Cancer Research and Treatment.

[23]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[24]  Alicja Wolk,et al.  Diabetes mellitus and risk of breast cancer: A meta‐analysis , 2007, International journal of cancer.

[25]  Jeffrey A. Johnson,et al.  Prospective Study of Hyperglycemia and Cancer Risk , 2007, Diabetes Care.

[26]  P. Hall,et al.  Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women , 2006, Cancer Epidemiology Biomarkers & Prevention.

[27]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  A. Wolk,et al.  Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study , 2006, International journal of cancer.

[29]  J. Klenk,et al.  Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria , 2006, Diabetologia.

[30]  S. Larsson,et al.  Diabetes mellitus and risk of colorectal cancer: a meta-analysis. , 2005, Journal of the National Cancer Institute.

[31]  J. Samet,et al.  Fasting serum glucose level and cancer risk in Korean men and women. , 2005, JAMA.

[32]  Graham A Colditz,et al.  Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.

[33]  M. Cotterchio,et al.  Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[34]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[35]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Kaaks,et al.  Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.

[37]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[38]  K. L. Pierce,et al.  Transactivation of the EGF Receptor Mediates IGF-1-stimulated Shc Phosphorylation and ERK1/2 Activation in COS-7 Cells* , 2000, The Journal of Biological Chemistry.

[39]  L. Bernstein,et al.  Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  R C Millikan,et al.  Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. , 2000, American journal of epidemiology.

[41]  B. Shilo,et al.  Insulin induces transcription of target genes through the hypoxia‐inducible factor HIF‐1α/ARNT , 1998, The EMBO journal.

[42]  A. Medline,et al.  Insulin promotion of colon tumors in rats. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  J. Cerhan,et al.  Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  E. Giovannucci.  Insulin and colon cancer , 1995, Cancer Causes & Control.

[45]  D. Coppola,et al.  A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor , 1994, Molecular and cellular biology.

[46]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[47]  G. Colditz,et al.  Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer , 2011, Breast Cancer Research and Treatment.

[48]  B. Hoffman,et al.  Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study , 2002 .